Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Baglivo
Observed names:
Baglivo, Sara,
S. Baglivo
Institution:
Azienda Ospedaliera di Perugia
Observed institutions:
University of Perugia,
Azienda Ospedaliera di Perugia,
Istituto Zooprofilattico Sperimentale dell'Umbria e delle Marche
ORCID:
0000-0002-4136-0577
Observed ORCID:
0000-0002-4136-0577
OpenAlex ID:
A5089948036
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis
2018
·
Biagio Ricciuti
, Carlo Genova
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
359
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
2018
·
Biagio Ricciuti
, Giulia Costanza Leonardi
, et al.
·
Pharmacology & Therapeutics
·
102
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs
2020
·
Matteo Canale
, Elisabetta Petracci
, et al.
·
Journal of Clinical Medicine
·
78
PDF
Targeting the KRAS variant for treatment of non-small cell lung cancer: potential therapeutic applications
2015
·
Biagio Ricciuti
, Giulia Costanza Leonardi
, et al.
·
Expert Review of Respiratory Medicine
·
70
Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer
2021
·
Martina Mandarano
, Elena Orecchini
, et al.
·
International Journal of Molecular Sciences
·
65
PDF
Future options for ALK-positive non-small cell lung cancer
2015
·
Daniela Iacono
, Rita Chiari
, et al.
·
Lung Cancer
·
57
Targeting NTRK fusion in non-small cell lung cancer: rationale and clinical evidence
2017
·
Biagio Ricciuti
, Marta Brambilla
, et al.
·
Medical Oncology
·
54
Safety and Efficacy of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer Treated Beyond Progression
2019
·
Biagio Ricciuti
, Carlo Genova
, et al.
·
Clinical Lung Cancer
·
53
Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer
2019
·
Paola Ulivi
, Elisabetta Petracci
, et al.
·
Journal of Clinical Medicine
·
53
PDF
Clinical impact of sequential treatment with ALK-TKIs in patients with advanced ALK-positive non-small cell lung cancer: Results of a multicenter analysis
2015
·
Rita Chiari
, Giulio Metro
, et al.
·
Lung Cancer
·
48
Osimertinib
2018
·
Umberto Malapelle
, Biagio Ricciuti
, et al.
·
Recent results in cancer research/Recent Results in Cancer Research
·
46
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
2017
·
Biagio Ricciuti
, Sara Baglivo
, et al.
·
Therapeutic Advances in Medical Oncology
·
41
PDF
Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience
2018
·
Biagio Ricciuti
, Sara Baglivo
, et al.
·
Therapeutic Advances in Respiratory Disease
·
40
Non-coding RNAs in lung cancer
2014
·
Biagio Ricciuti
, Carmen Mecca
, et al.
·
Oncoscience
·
39
PDF
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
2021
·
Giulio Metro
, Sara Baglivo
, et al.
·
Genes
·
38
PDF
Large Cell Neuroendocrine Carcinoma Transformation and EGFR -T790M Mutation as Coexisting Mechanisms of Acquired Resistance to EGFR-TKIs in Lung Cancer
2017
·
Sara Baglivo
, Vienna Ludovini
, et al.
·
Mayo Clinic Proceedings
·
33
PDF
High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients
2021
·
Vienna Ludovini
, Fortunato Bianconi
, et al.
·
Genes
·
29
PDF
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib
2018
·
Biagio Ricciuti
, Andrea De Giglio
, et al.
·
Medical Oncology
·
27
The safety of nivolumab for the treatment of advanced non-small cell lung cancer
2016
·
Giulio Metro
, Biagio Ricciuti
, et al.
·
Expert Opinion on Drug Safety
·
22
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab
2024
·
Carlo Genova
, Silvia Marconi
, et al.
·
Clinical and Experimental Medicine
·
21
RET Rearrangement as a Predictor of Unresponsiveness to Immunotherapy in Non-Small Cell Lung Cancer: Report of Two Cases with Review of the Literature
2020
·
Sara Baglivo
, Vienna Ludovini
, et al.
·
Oncology and Therapy
·
20
PDF
Wild-Type KRAS Allele Effects on Druggable Targets in KRAS Mutant Lung Adenocarcinomas
2021
·
Elisa Baldelli
, Emna El Gazzah
, et al.
·
Genes
·
19
PDF
Detection of EGFR Mutations in Plasma Cell-Free Tumor DNA of TKI-Treated Advanced-NSCLC Patients by Three Methodologies: Scorpion-ARMS, PNAClamp, and Digital PCR
2020
·
Annamaria Siggillino
, Paola Ulivi
, et al.
·
Diagnostics
·
19
PDF
Successful Response to Osimertinib Rechallenge after Intervening Chemotherapy in an EGFR T790M-Positive Lung Cancer Patient
2018
·
Giulio Metro
, Sara Baglivo
, et al.
·
Clinical Drug Investigation
·
19
Dramatic Response to Lorlatinib in a Heavily Pretreated Lung Adenocarcinoma Patient Harboring G1202R Mutation and a Synchronous Novel R1192P ALK Point Mutation
2018
·
Sara Baglivo
, Biagio Ricciuti
, et al.
·
Journal of Thoracic Oncology
·
17
PDF
Show more works
View as search
Works count:
71
Citation count:
1,516
H-index:
20
I10-index:
31
Year
Topic
Type